Dr David Baldwin is Honorary Professor of Medicine and Consultant Physician at Nottingham University Hospitals NHS Trust. He is Chair…
Supporting careers in clinical trials, interview with Dr Jenny Seligmann
'Dr Jenny Seligmann is a consultant medical oncologist and senior lecturer at the University of Leeds. She joined the NCRI…
Providing experience of clinical trials, interview with Dr Thomas Fox
'Dr Thomas Fox is a Haematology Registrar and Wellcome Trust Clinical PhD Fellow at University College London. He joined the…
Meeting experts in the field, interview with Dr Vinton Cheng
'Dr Vinton Cheng is an honorary Specialty Registrar in Medical Oncology at the Leeds Cancer Centre and Academic Clinical Lecturer…
Enabling prospective researchers to network and learn, interview with Dr Emma O’Dowd
'Dr Emma O’Dowd is a consultant respiratory physician at Nottingham University Hospitals NHS Trust. She joined the NCRI Screening, Prevention…
Supporting early career researchers, interview with Dr Iain Frame, NCRI CEO
'Dr Iain Frame is CEO of NCRI and was previously Director of Research at Prostate Cancer UK and Research Director…
Developing a research strategy for never smoker lung cancer patients
'The NCRI Lung Group has identified lung cancer in never smokers as a critical area of focus and recently hosted…
Reviewing guidance for pathology parameters to improve trial quality
'SPIRIT-Path is a project to develop international consensus guidance on the inclusion of pathology in clinical trial protocols. NCRI’s Cellular…
Prioritising COVID-19 research questions for the cancer population
'How co-designing research questions to understand what people with cancer want from COVID-19 research, informed some surprising results, and in…
Tribute to Professor Gordon McVie
'It’s with great sadness that the NCRI joins the cancer research community in paying tribute to Professor Gordon McVie who…
Using knowledge provided by NCRI research funding data to increase the impact of prostate cancer research
'Prostate Cancer Research recognised that with a large number of cancer research charities duplication was a possibility and that challenges…
What should we call patient representatives and advocates?
'The National Cancer Research Institute (NCRI) has led the way in involving patients, carers and other people with experience of…